Amryt (AMYT) Skin Disorder NDA Review Gets 3 Months Extension

Amryt (AMYT) is seeking approval for Oleogel-S10 for treating epidermolysis bullosa, a rare genetic skin disorder, in the United States and Europe. The FDA extends the review period for the…